Clik here to view.
Generon Presents the Global Phase II Study Results for F-627 (benegrastim) at...
SHANGHAI Generon (Shanghai) Corporation, a leading biopharmaceutical company in China, today announced the presentation of the global Phase II study results for F-627 (benegrastim) at the American...
View ArticleClik here to view.
Integra Holdings Closes $3 Million Investment from Guangxi Wuzhou...
JERUSALEM Integra Holdings, the biotechnology holdings company of Yissum, the technology transfer company of the Hebrew University of Jerusalem, announced today that it has received US $3 million...
View ArticleClik here to view.
昆泰啟動已上市產品維護服務，以便有效管理成熟產品
北卡羅萊納州三角研究園區 (美國商業資訊) – 昆泰今天發布了一項新服務，該服務將該公司業界領先的藥物警戒、法規文獻/說明書維護、收益風險管理和分析專業技能匯總成一套整合的解決方案。該解決方案將幫助生物製藥公司有效管理維護他們已上市產品陣容的授權所需的全部活動。...
View ArticleClik here to view.
Clik here to view.
Quintiles Named 2014 Frost & Sullivan Asia-Pacific CRO of the Year
SINGAPORE For the sixth time in eight years, Quintiles has been named Asia-Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and consulting...
View ArticleClik here to view.
糖尿病，利用胰脏细胞做根本性治疗的时代已经到来
首尔, 韩国 (美国商业资讯) — (株)STC LIFE(会长：李桂浩)干细胞治疗研究院(STC Stem cell Treatment & Research Institute / www.stcstri.com)通过数十年的研究成功利用能够分化为所有组织及脏器并无任何副作用的新万能细胞分化出担任胰脏中胰岛素调节机能的β细胞。 STC...
View ArticleClik here to view.
膵臓細胞利用により根本的治療の道が開かれる糖尿病 … STC Life、世界で初めて万能幹細胞から膵臓細胞への分化に成功
韓国・ソウル （ビジネスワイヤ） — STC Life Co., Ltd.（会長：KYE HO LEE）の幹細胞治療研究院（STC Stem cell Treatment & Research...
View ArticleClik here to view.
大冢制药收购Avanir Pharmaceuticals
东京 (美国商业资讯) – 大冢制药株式会社欣然宣布与Avanir Pharmaceuticals, Inc. (“Avanir”)签订一项协议，由大冢在美国的子公司Otsuka America, Inc.以35亿美元全额现金要约收购Avanir。该合同于日本时间12月2日签订。 Avanir Pharmaceuticals...
View ArticleClik here to view.
A New Era Comes When Diabetes Can Be Treated Basically Using Cells of Pancreas
SEOUL, South Korea STC Stem Cell Treatment & Research Institute (www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded in differentiating new pluripotent stem cells without...
View ArticleClik here to view.
Gynesonics Announces Another Peer-Reviewed Publication and Presentation of...
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the recent...
View ArticleClik here to view.
武田呈报研究中的Ixazomib单药用于新诊断多发性骨髓瘤患者巩固治疗的2期数据
旧金山 (美国商业资讯) — 武田药品工业株式会社(TSE:4502)今天发布了一项2期开放研究的结果，该研究评估口服ixazomib...
View ArticleClik here to view.
Otsuka and Lundbeck Present Phase III Data on Brexpiprazole as Adjunctive...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the efficacy of...
View ArticleClik here to view.
Cegedim Relationship Management与Aktana合作利用移动智能CRM为商业团队提供一个开箱即用的直观决策支持引擎
巴黎 (美国商业资讯)–Cegedim Relationship Management今天宣布，该公司已与为全球生命科学销售团队提供决策支持的先驱者Aktana达成战略合作伙伴关系，以完善Cegedim的移动智能客户关系管理(CRM)解决方案。为了通过...
View ArticleClik here to view.
Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce...
TOKYO & OSAKA, Japan & NEW YORK Ono Pharmaceutical Co.,Ltd. (Tokyo: 4528), Bristol-Myers Squibb Company (NYSE:BMY) and Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151,“Kyowa Hakko Kirin”) announced...
View ArticleClik here to view.
Clik here to view.
Acelity、ゴーラフ・S・アガーワルをビジネス・革新担当グループプレジデントに任命
サンアントニオ （ビジネスワイヤ） — Acelityは本日、ゴーラフ・S・アガーワルをビジネス・革新担当グループプレジデントに任命したと発表しました。これはAcelityの上級経営チームに新設された役職で、ジョー・ウッディ社長兼最高経営責任者（CEO）に直属します。この役職に就くアガーワルは、先進創傷治療と再生医療を含むAcelityの全事業の戦略的運営を主導します。...
View ArticleClik here to view.
Innovation Driving Positive Outlook for Pharma and Biotech in 2015
LONDON & BOSTON & TOKYO Innovation will continue to drive the pharma and biotech sectors in 2015 as forecasts point to another prosperous year according to EP Vantage’s latest report,...
View ArticleClik here to view.
Seattle Genetics和武田在ASH年会上发布ADCETRIS® (Brentuximab...
旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社 (TSE:4502)今天发布了ADCETRIS (brentuximab vedotin)治疗复发或难治全身性间变性大细胞淋巴瘤(ALCL)枢纽性2期临床试验的4年总生存(OS)数据。ADCETRIS是一种靶向作用于CD30的抗体药物轭合物...
View ArticleClik here to view.
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the...
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris® (eculizumab) has been granted orphan drug designation (ODD) by Japan’s Ministry of Health, Labour and...
View ArticleClik here to view.
Otsuka and Lundbeck’s Brexpiprazole Demonstrates Statistically Significant...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the effects of an...
View Article